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The chmnotmpic response to atropine is biphasic; low 
doses cause slowing of the sinus rate and high doses cause 
acceleration, Although it is accepted that atropine functions 
as a competitive antagonist at high doses, the mechanism of 
the negative chronotropic response at low doses is contro- 
versial. SpecitkaUy, it is unclear whether the effect Is 
mediated centrally or peripherally. Since at the time of 
cardiac replacement ali central nervous system connections 
to the heart are severed, the transplanted heart is a unique 
model for separating these effects. 
Graded doses of atrophte sulfate (0.5, 1.0,2.0,4.0,8.0 
and 40.0 &g body weight) were administered to 12 
humau heart transplant recipients to test the hypothesis 
that the bradycardiac effect of low dose atmpiue is centrally 
mediated. The baseline shuts cycle lengths of the deceutral- 
ixed donor and innervated native sinus nodes were 694 f 20 
aud 733 f 27 ms, respectively. At the 0.5 and I.0 ccglkg 
doses, the cycle lengths of the native sinus node increased 
by 29.1 + 13.5 and 23.1 f 14.2 ms, respectively. At the 2.0 
clglkg dose the siuus cycle length again shortened to con- 
trol. At the maximai dose of atmpiue the sinus cycle length 
shortened by 138.3 f 29.7 ms compared with coutroi. In 
contrast, the deceutralixed onor sinus node exhibited a fiat 
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dose response to atropiue. Wigh dose atropiue (40 
caused no change in the donor heart’s atria1 effective 
refractory period, corrected sinus node recovery time, or 
siuoatriai conduction time measured by eitber the Strauss 
or the Narula method. 
In summary, low dose atrop 
length of the decentralized on 
eued the cycle length of the inuerva 
High dose atropiue similarly 
length of the decentraliid donor sinus node, but it short- 
ened the cycle length of the innervated native sinus node. 
Wigb dose atropiue also had no effect on atrial refractori- 
ness, sinus uode recovery time or siuoatriai conduction time 
in the decentralized onor heart. Thus, results suggest 
tbat in humans a central site of action is cieut to explain 
the transient bradycardia caused by low dose atropine and 
that the effect depends on intact central neural couuectious. 
Tbe data also confirm that high dose atropiue has no direct 
or indirect effect on the human transplanted heart. Ai- 
though atropiue may have central and peripheral cardiac 
effects, central effects are probably of greater importance. 
(J Am Co11 Car&d 1990;15:P610-7) 
accelemtion (i-9). Although it is accepted that atropine 
functions as a competitive antagonist at postsynaptic mus- 
cariuic receptors when administered in high doses (lo), the 
mechanism of the negative chronotropic response to low 
dose atropine is uncertain (4,7,11). Several mechanisms for 
the negative chrouotropic action of atropine have been 
proposed. These include stimulation of vagal centers in the 
medulla (2-4,6,7,10,12), stimulation of muscarinic receptors 
on pacemaker cells of the sinus node (4,6,7,10,13), direct 
effects independent of muscarinic receptors on the pacc- 
maker cells (2,6,7), anticholinesterase inhibition (5,7,13,14), 
presynaptic modulation of norepinephrine release by inhib- 
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T&k 1. Demographics of 12 SPudy 
Patient No. 
Age (yrli 
Gender 
Procwement 
No. - 
Drugs 
Days Episodes Donor 
Disease After TX We.jection L/D Time (mm) Age WI Cy Pred Aza Nif Other 
I 53/F CAD 12 0 D 101 17 x X 
2 44/F CAD 17 0 D 155 19 X X X 
3 511M AVD 23 I D 190 31 x x x 
4 59/M CAD 17 0 D 245 29 X X X Digoxin (for AF) 
5 54/M CAD 22 0 L 83 20 X X X Amiodarone (leve’ 3.8 
&ml) 
6 58/M CAD 28 0 D 146 33 X X X 
7 25lF CAD 32 I D 103 22 x X X 
8 48/M CAD 29 0 D 232 23 x X X X 
9 42/M RHD 21 0 D 210 22 X X X X 
IO 60/F AQD 19 0 L 102 16 X X X 
11 49&i CAD 23 0 L 257 20 X X X Albuterol, theophylline 
I2 54/M IDCM I3 0 L 180 24 X X X X Amitriptyline 
Mean 2 SE 49.8 k 2.8 21.3 i: 1.8 0.2 + 0.1 167 2 18 23.0 f I.0 
AF = atria! flutter: AVD = aortic valve disease: Am = uathioprinr: CAD = coronary art:ry disease; Cy = cyclosporine; F = female; lDCM = idiopathic 
dilated cardiomyopathy: L/D = local/distant; M = male; Nit’ = nifedipine: Pred = prednisore: RH = rheumatic heart disease; TX = transplant. 
itory muscarinic rece ors on adrenergic nerves (15,16) and 
stimulation of nicoti receptors in vagal ganglia (2). 
The transplanted heart is a unique model for the study of 
cardiac electrophy e heart is permanently 
decentralized and nervous system inllu- 
ences (i7==19). The ter lized” rather than “de- 
nervated” is used to describe the donor heart since there is 
postganghonic separation from central sympathetic centers 
but preganglionic separation from central parasympathetic 
centers. Because the innervated native sinus node is left in 
place at the time of transplantation, a unique situation exists 
in which both innervated (native) and decentralized (donor) 
sinus nodes are present in the same individua!. Conse- 
quently, the respective responses of the two sinus nodes to 
specific stimuli can be compared. Furthermore, since the 
interruption of central influence is not 
intervention, potentially confounding 
tally active drugs are avoided. Fina 
serve as his or her own control. We administered atropine in 
graded doses to 12 human heart transplant recipients to test 
the hypothesis that the bradycardiac effect of low dose 
atropine is primarily due to effects in the central nervous 
system. 
atients. Twelve patients (eight men and four 
women) with a mean age of 49.8 XL 2.8 years who underwent 
successful orthotopic cardiac transplantation were studied 
after they gave fully informed consent (Table I). This 
protocol was approved by the Institutional Review Board of 
the University of Alabama at Birmingham. 
e. All cardiac tra~s~~a~tatio~s 
iversity of Alabama Hospital. 
rstant organ procurement was used for eight patients. 
min (mean 167 * 18). Transplantation was carried out with 
standard techniques (20). The donors’ ages ranged from 16 to 
33 years (mean 23.0 2 1.0). The don r and recipient right 
atria were anastomosed posteriorly an laterally and special 
care was taken to protect the donor nus node by tigating 
and dividing the donor superior vena cava 1 to 2 cm above 
the cavoatrial junction (20). At the end of the transplantation 
procedure, pairs of temporary stainless steel wire electrodes 
were placed on the recipient right atrial cuff, the donor right 
atrial cuff and the donor right ventricle (21). 
hysiologic study. Each patient was studied in the 
alert, fasting state without premeditation by using the tem- 
porary stainless steel wire electrodes for both recording and 
stimulation. The studies were performed 21.3 -+ 1.8 days 
(range 12 to 32) after the transplantation procedure. The two 
patients who experienced rejection were studied only after 
having subsequent normal myocardial biopsy results. Elec- 
trocardiographic (ECG) leads 1, 11, III and V, and bipolar 
electrograms were recorded simultaneously on a V 
switched beam oscilloscopic recorder (Electronics-for- 
Medicine) and on FM magnetic tape; a 56OOC recorder 
(Honeywell) was used for later playback and analysis. All 
electrophysiologic measurements were made at a paper 
speed of 100 mm/s. The ECGs were recorded between a 
bandpass of 0.05 and 25 Hz and the electrograms were 
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Figure 1. Representative recording from an electrophysiologic 
study. From top down are standard electrocardiographic leads I, II 
and V,, epicardial electrograms from the native (innervated) and 
donor (decentralized) right atrial (RA) cuffs and the right ventricular 
(RV) donor electrogram (vJ. Note that the right atrial native 
electrogram (a,,) is dissociated from the right atrial donor electro- 
gram tad)- 
filtered between a bandpass of 10 and 500 Hz. Pacing was 
performed with a constant current, programmable stimulator 
(Bloom Associates) at twice the diastolic threshold. 
Each patient remained quietly at rest before any record- 
ing or pacing was undertaken. The native and donor sinus 
cycle lengths were then measured (Fig. 1) and recorded as 
the mean of at least 15 consecutive depolarizations. Pacing 
was performed only on the donor heart. During sinus 
rhythm, premature atrial stimuli were introduced and dias- 
tole scanned until the atria1 effective refractory period was 
determined and an attempt was made to record the sinus 
node effective refractory period (22). 
Pacing was thereajler undertaken using a single basic 
drive Lycle length (eight beats) and single atria1 extrastimuli 
were introduced. The donor atria1 effective refractory period 
was thereby redefined and the data were used to calculate 
the sinoatrial conduction time with the method of Strauss et 
al. (23). The atrium was paced for 8 beats at a rate less than 
10 beats faster than the donor sinus rate and the sinoatrial 
conduction time recalculated with the method of Narula et 
al. (24). The donor sinus node recovery time was then 
determined by incremental atria1 pacing beginning with the 
iirst pacing rate within 10 beats of the donor sinus rate. The 
corrected sinus node recovery time was determined as the 
difference between the maximal sinus node recovery time 
and the donor atria1 cycle length before pacing (25). 
Atropine ~~~inist~tio~. Atropine sulfate, USP was ad- 
ministered by bolus injection via a peripheral vein to achieve 
cumulative doses of OS, 1.0, 2.0, 4.0, 8.0 and 40.0 @kg. 
The time between doses was 4 min. At each dosage level the 
native sinus cycle length, the donor sinus cycle length and 
the systemic blood pressure (by arm cuff) were measured. 
Four minutes after administration of the last dose of atropiue 
(total dose 40 &kg) the entire set of electrophysiologic 
variables was remeasured. 
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(n = (n = 11) (n = 11) Cn = 
Baseline 259 f II 894 i: 37 1% ‘- 22 137 2 18 67 f 17 
Atropine (40 &kg) 2662 II 914 + 37 195 t 19 134 k 16 70 2 19 
Change after a&opine 7.0 + 3.7 19.5 k 6.7 -1.4 -c 10.1 -2.4 k 6.2 2.3 f 7.9 
p value 0.09 0.02 0.90 0.71 0.75 
AERP = atrial effective refractory period; CSNRT = corrected sinus node recovery time; SACTN = sinoatrial conduction time by the Narula method; S,~CTs 
= sinoatrial conduction time by the Strauss method: SNRT = sinus node recovery time. All data are mean values + SE recorded in milliseconds. 
onor heart’s sinus cyc 
baseline were assessed with standard general linear regres- 
sion model techniques. To make comparisons between the 
native and donor dose response curves, the mean estimated 
cients for each we 
variate analysis of varia 
person (26). A p value 
significant. 
As expected at baseline, 
th donor decentralized hearts 
was shorter (693.9 -C 19.6 ms, n = 12) than the mean sinus 
cycle length of the native innervated hearts (732.5 2 26.6 ms, 
n = 8) (Table 2). The sinus cycle length in four of the native 
hearts could not be measured because of inconsistent elec- 
trical activity in two patients and marked sinus arrhythmia 
and atrial fibrillation in one patient each. The mean baseline 
donor atria1 effective refractory period, sinus node recovery 
time, corrected sinus node recovery time and sinoatrial 
cijpduction times (measured with the Strauss [23] and Narula 
[24] methods) are shown in Table 3. 
on sinus cycle len . The changes in 
cycle length of the native and donor hearts in response to the 
graded doses of atropine are presented in Table 2 and shown 
graphically in Figure 2. At the 0.5 and 1.0 &kg doses the 
cyc!c lengths of the innervated native sinus node increased 
by 29.1 + 13.5 and 23.1 r 14.2 ms, respectively. At the 2.0 
ccglkg dose the cycle length shortened again to control (the 
cycle length before atropine administration). At the maximal 
dose of 40 &kg the sinus cycle length had shortened by 
138.3 r 29.7 ms. In contrast, the decentralized donor sinus 
node exhibited a flat dose response to atropine. There was 
no significant difference in the sinus cycle length after any 
baseline (p = 0.81). Thus, a 
ycle length was demonstrated 
e ~~~e~ated native but not the decentralized donor 
pine doses the nativ 
rate slowed) and at 
0.02). The mean bioo 
atropine administrati 
atropine dose range (p = 0.11). 
c&i on ~~~~~~~~~~~~S 
tive refractory period cou 
ne dose because there wa 
tion time during the introduction of progressively shorter 
ive refractory period of 
n response to maximal 
t this did not achieve 
le 3). Although the 
smus node lengthened 
after the 40 pg/kg dose of atropine by 19.5 C 6.7 ms (p = 
0.02), there was no significant change in the corrected sinus 
node recovery time, which decreased by 1.4 i 10.1 ms (p = 
(Table 3). The sinoatrial 
conduction time of the donor heart measured by both the 
Strauss and the Narula method was not significantly different 
after maximal atropine dose administration compared with 
control. 
The main conclusion from our study is that the negative 
chronotropic effect of low dose atropine depen n intact 
central neural connections to the sinus node. results 
extend those of earlier investigations (l-14,18,19,27) by 
providing not only dose response data for a&opine effects 011 
the neurally intact human sinus node but also more informa- 
tion regarding sinus node function in the decentralized 
transplanted heart. No effect of atropine on automaticity, 
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P: Basslins vs I-SN = 0.01 
Saschine vs O-SN = 0.61 
I-SN vs O-SN = 0.02 
i.0 2.0 
ATROPINE DOSE (mcg/kg) 
conduction or refractoriness could be demonstrated in the 
human decentralized sinus node or atrium. 
Site of atropine action. There is experimental evidence 
that the negative chronotropic action of atropine is mediated 
by both central and peripheral mechanisms. The majority of 
these studies were performed in animals or in anesthetized 
humans. Interspecies variation to the antimuscarinic actions 
of atropine, the effects of anesthesia and the doses of 
atropine administered all confound interpretation of these 
results and make it di5cult to extrapolate the results to 
humans (28). 
Kottmeier and Gravenstein (6) administered atropine 
methylbromide and atropine sulfate to unanesrhetized, 
awake dogs in cumulative doses. Low doses of both drugs 
caused slowing of the sinus rate; high doses accelerated the 
sinus rate. Because atropine methylbromide is incapable of 
crossing the blood-brain barrier, it was suggested that the 
parasympathomimetic effect of this drug as well as of atro- 
pine sulfate was mediated peripherally (6). A ganglionic or 
pos$anglionic site of action could not be excluded by these 
experiments. Furthermore, the possibility that atropine sul- 
fate had a central vagal stimulating effect was not excluded 
(6). 
Abundant evidence substantiates the presence of acetyl- 
choline-sensitive neurons in the central nervous system (29). 
The excitatory effects of acetylcholine are generally weak 
and unpredictable, with the number of sensitive cells and 
intensity of the response varying even within the same 
al0 
Figure 2. The mean changes in cy- 
cle length (A CL) in miiliseconds 
after administration of graded atro- 
pine doses are shown on a logarith- 
mic scale. At atropine doses of 0.5 
and 1 .O &kg, the mean sinus cycle 
length of the innervated native si- 
nus nodes (MN) increased, indi- 
cating a decrease in rate. At the 2 
pglkg dose the baseline was 
crossed and the sinus cycle length 
began to shorten, indicating an in- 
crease in rate. The administration 
of atropine up to the maximal dose 
of 40 pg/kg led to continued shoti- 
ening of the native sinus cycle 
length. This increase and decrease 
in sinus cycle length is the expected 
biphasic response seen in the nor- 
mal heart. In contrast, the sinus 
cycle length of the decentralized 
donor hearts (MN) remained un- 
changed over the ez.tire dose range 
of atropine. The mean sinus cycle 
length of the innervated native si- 
nus nodes was significantly dif- 
ferent from both baseline and the 
mean cycle length of the decentral- 
ized donor sinus nodes. 
species. The excitatory effects have been noted to be ex- 
tremely vulnerable to depression by anesthetics. Neverthe- 
less, acety1cholir.e also has been shown to cause depression 
of neuronal firing in the central nervous system with the 
effects being largely muscarinic and prevented by atropine 
(29). Indeed, early studies on the effects of small doses of 
atropine on heart rate concluded that transient slowing was 
mediated centrally (l-6). Katona et al. (8) suggested that the 
central and peripheral effects of atropine are opposed and 
that the drug stimulates efferent vagal activity centrally 
while simultaneously blocking the vagal effect on heart rate 
peripherally. They concluded that although “an initial pe- 
ripheral stimulating effect (causing bradycardia) cannot be 
ruled out, it is unnecessary at the present to invoke the 
existence of such a mechanism” (8). 
The most convincing evidence for (I centrul excitutory 
mtion of cctropine WNS provided by Gilbey et al. (30). 
Recordings of neural traffic from cardioinhibitory neurons in 
the region of the nucleus ambiguus in cats showed that 
neural activity increased during expiration and decreased 
during inspiration. The ionophoretic application of acetyl- 
choline to these neurons reduced neural discharge and 
atropine antagonized this effect (30). Xoreover, when atro- 
pine was administered either alone or with acetylcholine, 
neuronal discharge increased, even during inspiration. Thus, 
atropine clearly has central parasympathetic effects. 
Recent investigations (15,16) have shown that there is 
prejunctional modulation of adrenergic neurotransmission 
JAW Vol. 15. No. 7 
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Thus, there is evidence that at~o~~~~e agects siuus rate 
ceutrahy, ?e~~pbe~a~ly and by i~~te~~~tio?l bet~~~eev~ the sya- 
pathetic and ~arasy~~atbeti~ rtervous s,vstems at ~~~~l~~i(~~~i~. 
to account for the drug’s e 
Unfortunately, the model 
nesterase activity, co 
shortening of the atrial refeactory period by atrop~~e implies 
that vagotonia prolongs atria! refractoriness in humans, 
Prystowsky et al. (32) argued that enhanced vagal tone 
shortens the atria! refractory p in humans. In a patient 
with sick sinus syndrome, Re et al. (33) showed that 
there was ““paradoxical” prowl ation of the sinus node 
recovery time after atropine administration. In our study, 
high dose atropine appeared to have no effect on these 
electrophysiologic variables in the decentrahzed heart. The 
absence of an effect provides further inferential support for 
the hypothesis that central mechanisms are also sufficient to 
explain atropiae’s various egects on automaticity, conduc- 
tion and refractoriness. 
~irni~t~o~s,, There are several limitations to our stuuy. 
First, conclusions regarding atropine effects on cardiac 
electrophysiology are dependent in the assu 
muscarinic receptors are present in the transplanted heart. 
There is independent evidence that not only postgnngliouic 
neuroas (34) but also functional choliuergic receptors (353 
are present in the transplanted heart. Napolitarm et 21. (34) 
presented electron microscopic evidence for the presence of 
neural elements, presumed to be ganglia, in the transplanted 
canine atrium. We did not administer acetylcholine to our 
(38) gave edropho~i 
Is and concluded t 
ever, their dose of edro- 
and they concluded that “the possibil- 
e may have significant, direct electro- 
ertheless. although statistical significance was not shown, 
n the donor atrial cycle length 
suggesting that some choliner- 
gic response may have been present (38). 
A second limitation is that other drugs that the patients 
were receiving 9nuy he confounded the results. Specifi- 
cally. three patients were receiving nifedipine and one 
patient each was receiving digoxin and amitriptyli 
ervated native sinus node of thes 
behaved no differently from that of the others, indicating that 
any effects were minor. 
Finally, a third limitation is that the absence of a periph- 
eral effect of atropine does not absolutely exclude au indi- 
rect eflect present in the innervated heart, such as during 
accentuated antagonism and reciprocal excitation (15,16). 
For example, if peripheral atropine action is dependent on 
intact sympathetic innervation, the failure to demonstrate an 
atropine effect would reflect only the absence of sympathetic 
innervation and be a secondary phenomenon. Regardless, 
given the inherent hmitations of our model, the data do allow 
US to conclude that in the absence of innervation neither high 
nor low dose atropine has an effect on the denervated 
transplanted sinus node. 
&buuterbalaucing these limitations is the fact that since 
the donor hearts were ah from young persons, there was an 
increased chance of identifying a response if one was present 
(40,41). Although it may be argued that the native sinus node 
does not provide for etfective comparison because heart 
disease has been shown to alter autonomic function @Q-44)+ 
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the normal, biphasic response to atropine shown by the 
native sinus node, despite the presence of severe heart 
disease, suggests that the comparison is valid. Ellenbogen et 
al. (45) showed a reversal of arterial baroreflex abnormalities 
after cardiac transplantation. 
Clinical implications, The methods used in this investiga- 
tion permit the study of electropharmacology in the human 
heart in vivo without the confounding influences of pharma- 
cologic denervation or anesthesia. Understanding of the 
maintenance and control of sinus rhythm provides the basis 
for establishing new means for treating disorders of cvdiac 
impulse initiation and propagation seen both in the general 
population (for example, patients with sick sinus syndrome) 
and in heart transplant patients. As the number of heart 
transplant patients increases, sinus node dysfunction has 
been recognized with increased frequency and has led to 
pacemaker implantation in an important subset of transplant 
recipients (46-48). 
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acknowledged. The expert secretarial assistance of Lori Hagglund in the 
preparation of this manuscript is greatly appreciated. 
eferences 
I. Wilson FN. The production of atrioventricular rhythm in man after the 
administration of atropin. Arch Int bled 1915:16:989-1007. 
2. McGuigan H. The effect of small doses of atropin on the heart rate. JAMA 
1921;76: 1338-40. 
3. Morton HJV, Thomas ET. Effect of atropine on the heart-rate. Lance1 
19S8:2: 1313-5. 
4. Averill KH. Lamb LE. Less commonly recognized actions of atropine on 
cardiac rhythm. Am J Med Sci 1959:237:304-18. 
5. Ashford A, Penn GB, Ross JW. Cholinergic activity of atropine. Nature 
1%2:193:1082-3. 
6. Kottmeier CA. Gravenstein IS. The parasympathomimetic activity of 
atropine and atropine methylbromide. Anesthesiology I-29: 1125-33. 
7. Das G. Talmers FN, Weissler AM. New observations on the effects of 
atropine on the sinoatrial and atrioventricular nodes in man. Am J Cardiol 
1975:36:281-S. 
8. Katona PG, Lipson D. Dauchot PJ. Opposing central and peripheral 
effects of atropine on parasympathetic cardiac control. Am 3 Physiol 
1977;232:Hl46-51. 
9. Hirschowitz BI, Molina E, Ou Tim L, Helman C. Effects of very low 
doses of atropine on basal acid and pepsin secretion, gastrin. and heart 
rate in normals and DO. Dig Dis Sci 1984;29:790-6. 
lo. Innes IR, Nickerson M. Atropine. scopolamine, and related antimuscar- 
inic drugs. In: Goodman LS, Gilman A, eds. The Pharmacologic Basis of 
Therapeutics. New York: Macmillan, 1975516-9. 
11. Hirschowitz BI, Molina E. Classification of muscarinic effects on gastric 
secrelion and heart rate in intact dogs. Trends Pharmacol Sci 1984; 
(suppl):69-73. 
12. Heinekarnp WJR. The central influence of atropine and hyoscine on the 
heart rate. J Lab Clin Med 1922:8:104-l 1. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
2s. 
Liillmann H, Fiirster W, Westermann E. ijber eine “paradoxe” Atropin- 
wirkung an isolierten Organen und ihre statistische Erfassung. Arch 
Exper Path Pharmakol 1952:215:8-18. 
Liillmann H. ijber einen Synergismus zwischen Atropin und Acetylcho- 
lin. Arch Exper Path Pharmakol 1952;216:152-3. 
Levy MN. Sympathetic-parasympathetic interactions in the heart. Circ 
Res 1971;29:437-45. 
Vanhoutte PM, Levy MN. Prejunctional cholinergic modulation ofadren- 
ergic neurotransmission in the cardiovascular system. Am J Physiol 
1980;238:H275-81. 
Kent KM, Cooper T. The denervated heart: a model for studying 
autonomic control of the heart. N Engl J Med 1974;291:1017-21. 
Harrison DC, Mason JW. Schroeder JS. Stinson EB. Effects of cardiac 
denervation on cardiac arrhythmias and electrophysiology. Br Heart J 
1978:40(suppl):17-23. 
Mason JW. Harrison DC. Electrophysiology and electropharmacology of 
the transplanted human heart. In: Narula OS, ed. Cardiac Arrhythmias: 
Electrophysiology, Diagnosis and Management. Baltimore: Williams & 
Wilkins, 197956-81. 
Kirklin JW. Barrat-Boyes BG. Primary cardiomyopathies and cardiac 
transplantation. In: Cardiac Surgery. New York: Wiley, 1986~1409-32. 
Harris PD. Singer DH. Malm JR, Hoffman BF. Chronically implanted 
cardiac electrodes for diagnostic, therapeutic, and investigational use in 
man. J Thorac Cardiovasc Surg 1%7;54:191-8. 
Kerr CR, Strauss HC. The measurement of sinus node refractoriness in 
man. Circulation 1983~68*1231-7 9. . 
Strauss HC, Saroff AL, Bigger JT, Giardina EGV. Premature atrial 
stimulation as a key to the understanding of sinoatrial conduction in man: 
presentation of data and critical review of the literature. Circulation 
1973;47:86-93. 
Narula OS. Shantha N. Vasquez M. Towne WD, Linhart JW. A new 
method for measurement of sinoatrial conduction time. Circulation 1978; 
S&706-14. 
Mandel W. Hayakawa H, Danzig R. Marcus HS. Evaluation of sine-atrial 
node function in man by overdrive suppression. Circulation 1971:44:59- I. 
00. ,. 
26. Box GEP, Hunter WG. A useful method for model building. Technomel- 
rics 1%2:4:301-18. 
27. Cannom DS, Graham AF. Harrison DC. Electrophysiological studies in 
the denervated transplanted human heart. Circ Res 1973:32:268-78. 
28. Tanz RD. Kloka A, Harwood B. Rightmier D. Negative chronotropic and 
antiarrhythmic properties of atropine and other tropane analogues on 
isolated cat heart preparations. Circ Res 1978;42:467-73. 
29. KrnjeviC K. Central cholinergic pathways. Fed Proc 1%9;28:113-20. 
30. Gilbey MP. Jordan D, Richter DW. Spyer KM. Synaptic mechanisms 
involved in the inspiratory modulation of vagal cardio-inhibitory neuronrs 
in the cat. J Physiol 1984;356:65-78. 
31. Dhingra RC. Amat-Y-Leon F, Wyndham C, et al. Electrophysiologic 
effects of atropine on human sinus node and atrium. Am J Cardiol 
1976;38:429-34. 
32. Prystowsky EN, Naccarelli GV, Jackman WM. Rinkenberger RL. Heger 
JJ. Zipes DP. Enhanced parasympathetic tone shortens atrial refractori- 
ness in man. Am J Cardiol 1983;51:%-100. 
33. Reiffel JA, Bigger JT. Giardina EGV. “Paradoxical” prolongation of 
sinus nodal recovery time after atropine in the sick sinus syndrome. Am 
J Cardiol 1975;36:98-104. 
34. Napolitano L, Cooper T. Willman VL, Hanlon CR. Fine structure of the 
heart after transplantation: with special reference to the neural elements. 
Circulation 1964;29(suppl):81-5. 
35. Nellessen U. Lee TC, Fischell TA. et al. Effects of acetylcholine on 
epicardial coronary arteries after cardiac transplantation without angio- 
graphic evidence of fixed graft narrowing. Am J Cardiol 1988;62:1093-7. 
JACC Vol. 15. No. 7 
June 1990~1610-7 
36. Bkumura K. Yasue H, Matsuyama K, et al. Sensitiviny and specificity of 
intracoronary injection of acetylcholine for the induction of coronary 
artery spasm. J Am Coil Cardiot l988:t2:883-8. 
37. James TN. Anatomy of the coronary arteries in health and disease. 
Circulation 1%5;32: 1020-33. 
Mason JW, Harrison DC. ~~ectrophysiolog~ca~ 
in the innervated and tbe transplanted denervated 
human heart. Br Heart J 1978;40:644-9. 
39. McConnell MC, Simpson LL. The role OF acetylcholine receptors and 
acetylcholinesterase activity in the development ofdenervation supersen- 
sitivity. J Pharmacol Exp Titer 1976:198:507-17. 
40. Dauchot P. Gravenstein JS. Effects ofatropine on the electrocardiogram 
in different age groups. Clin Pbarmacol Ther 1971:12:274-80. 
41. Cappato R. Alboni P, Paparella N, Toselli T, Candini CC. Tomasi AM. 
Bedside evaluation of sinus bradycardia: usefulness of au-opine test in 
discriminating organic from autonomic involvement of sinus automaticity. 
Am Heart J 1987;114:1384-8. 
42. E&berg DL, Dwbinsky Braunwald E. Defective cardiac parasympa- 
thetic control in patients with heart disease. N Engl J Med 1971:285:877- 
83. 
43. Coldstein RE. Beiser CD. Stampfer M, Epstein SE. Impairment of 
au~onomicahy mediated heart rate control in patiems with cardiac dys- 
Function. Circ Res 1975;36:571-8. 
44. Amorim DS, Deer K, Jenner D, et al. Is there autonomic impairment in 
congestive (dilated) cardiomyopathy? Lance1 1981;1:525-7. 
45. Ellenbogen KA. Mohanty PK. Szentpetery S. Thames MD. Arterial 
baroretlex abnormalities in heart failure: reversal after orthotopic cardiac 
transp~an~tion. Circulation 1989;79:51-8. 
46. Mackintosh AF, Carmichael DJ, Wren C, Gory-Pearce R, English TA 
nus node function in first three weeks after cardiac transplantation. 
earl J 1982:48:584-B. 
xton RS. Nathan AW, Hetlestrand KJ, et al. 
abnormalities in the transplanted human heart. Br 
63. 
48. Zmyslinski RW, Warner MG. Diethrich EB. Symptomatic sinus node 
dysfunction after heart transplantation. PACE 1988:11:445-8. 
